Exclusive

Publication

Byline

Novartis signs licensing deal worth $7.2 B with China's Abogen for mRNA therapies

Singapore, Oct. 7 -- China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered into a licensing and option agreement with Novartis to advance ... Read More


AstraZeneca opens new global strategic R&D centre in Massachusetts, US

Singapore, Oct. 7 -- AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, US. The new state-of-the-... Read More


Docquity extends Asian healthcare intelligence to Japan through deepened strategic partnership with exMedio

Singapore, Oct. 7 -- Docquity, the Singapore-based clinical AI platform for more than 75% of verified doctors across Asia, has announced its scale up plan into Japan through a deepened strategic partn... Read More


Qiagen expands AI-powered bioinformatics for research and drug discovery

Singapore, Oct. 7 -- Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and genomic data faster while keeping the scientific evidence beh... Read More


Singapore injects S$50 M into National Centre for Engineering Biology

Singapore, Oct. 6 -- The National Centre for Engineering Biology (NCEB), hosted at the National University of Singapore (NUS), has been officially launched together with its new research facility. De... Read More


Japan-Ghana partnership to advance next-generation vaccine R&D

Singapore, Oct. 6 -- Japan-based Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), led by Director Hiroshi Kiyono, has signed a Memorandum of Unders... Read More


Merck inks up to $2.13 B oncology deal with China's SciBrunch

Singapore, Oct. 6 -- Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered into an exclusive global license agreement for SPR2015, an... Read More


Taiwan's Energenesis Biomedical joins hands with Korea-based Yoo Young Pharm to develop treatment for diabetic foot ulcers

Singapore, Oct. 6 -- Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South Korea-based pharmaceutical company, to explore a collaborati... Read More


Korea's SK pharmteco invests more than $200 M to expand small molecule and peptide capacity in US

Singapore, Oct. 6 -- SK pharmteco, a subsidiary of SK Inc., the strategic investment company for SK Group, South Korea's second-largest conglomerate, has announced a comprehensive five-year, more than... Read More


Vitalant launches cell-based analytics lab to support allogeneic therapy developers

Singapore, Oct. 6 -- Vitalant, one of the nation's largest nonprofit blood and biotherapies healthcare organisations, has announced the launch of its analytics lab at the Phoenix Bioscience Core, expa... Read More